• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

The deal is a bet on the growing market for psychiatric and neurological drugs.

Lauren Hirsch
Author: Lauren Hirsch

Written by

Lauren Hirsch

in

Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Mental Health and Disorders, Mergers, Acquisitions and Divestitures
←Trump Insists He’s ‘Not A Student Of Hitler’ While Defending ‘Poisoning The Blood’ Comments About Immigrants
Joe Rogan Corrected On His Own Show For Dissing Biden…By Quoting Trump→

More posts

  • Why This Josie Maran Body Butter is My Holy Grail 

  • Aluminium, Helium and Sulfur: The Iran War Is Affecting More Than Oil

  • Senate Moves Toward Passing Sweeping Housing Bill, but Challenges Lie Ahead

  • Girl, Log Off: A Guide To Recharging On National Day Of Rest For Black Women

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube